The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight‐obese individuals consuming pomegranate: A randomized clinical trial
Abstract
Scope: The pomegranate lipid‐lowering properties remain controversial, probably due to the interindividual variability in polyphenol (ellagitannins) metabolism. Objective: We aimed at investigating whether the microbially derived ellagitannin‐metabolizing phenotypes, i.e. urolithin metabotypes A, (UM‐A), B (UM‐B), and 0 (UM‐0), influence the effects of pomegranate extract (PE) consumption on 18 cardiovascular risk biomarkers in healthy overweight‐obese individuals. Methods and results: A double‐blind, crossover, dose–response, randomized, placebo‐controlled trial was conducted. The study (POMEcardio) consisted of two test phases (dose‐1 and dose‐2, lasting 3 weeks each) and a 3‐week washout period between each phase. Forty‐nine participants (BMI > 27 kg/m 2) daily consumed one (dose‐1, 160 mg phenolics/day) or four (dose‐2, 640 mg phenolics/day) PE or placebo capsules. Notably, UM‐B individuals showed the highest baseline cardiovascular risk. After dose‐2, total cholesterol (–15.5 ± 3.7%), LDL‐cholesterol (–14.9 ± 2.1%), small LDL‐cholesterol (–47 ± 7%), non‐HDL‐cholesterol (–11.3 ± 2.5%), apolipoprotein‐B (–12 ± 2.2%), and oxidized LDL‐cholesterol –24 ± 2.5%) dose dependently decreased (P < 0.05) but only in UM‐B subjects. These effects were partially correlated with urolithin production and the increase in Gordonibacter levels. Three (50%) nonproducers (UM‐0) became producers following PE consumption. Conclusions: UM clustering suggests a personalized effect of ellagitannin‐containing foods and could explain the controversial pomegranate benefits. Research on the specific role of urolithins and the microbiota associated with each UM is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
Diet–microbiota interactions as moderators of human metabolism
Sonnenburg, J. L., & Bäckhed, F. (2016) · Nature · doi:10.1038/nature18846 · Cited by 2,257
Interaction between Phenolics and Gut Microbiota: Role in Human Health
Selma, M. V., Espín, J. C., & Tomás-Barberán, F. A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf902107d · Cited by 1,324
Self-citationRyu, D., Mouchiroud, L., Andreux, P. A., Katsyuba, E., Moullan, N., Nicolet-dit-Félix, A. A., Williams, E. G., Jha, P., Lo Sasso, G., Huzard, D., et al. (2016) · Nature Medicine · doi:10.1038/nm.4132 · Cited by 1,105
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
Boekholdt, S. M., Hovingh, G. K., Mora, S., Arsenault, B. J., Amarenco, P., Pedersen, T. R., LaRosa, J. C., Waters, D. D., DeMicco, D. A., Simes, R. J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.615 · Cited by 581
Research works printed but not linked: 48
- Kim S. H., 2015, Obesity and cardiovascular disease: friend or foe?, Eur. Heart J.
- 10.1016/j.cmet.2013.05.009 · DOI
- Jain K. K., 2002, Personalized medicine, Curr. Opin. Mol. Ther., 4, 548
- 10.1079/BJN20051565 · DOI
- 10.1038/ejcn.2014.23 · DOI
- 10.1002/ptr.5280 · DOI
- 10.1002/mnfr.201500227 · DOI
- 10.1016/j.nutres.2014.08.003 · DOI
- 10.5812/ijem.33835 · DOI
- Kojadinovic M. I., 2016, Pomegranate juice consumption decrease blood lipid peroxidation and level of arachidonic acid in women with metabolic syndrome, J. Sci. Food Agric.
- 10.1016/j.phymed.2015.12.014 · DOI
- 10.1016/j.copbio.2012.09.009 · DOI · Paper page
- 10.1021/jf5024615 · DOI · Paper page
- 10.1002/mnfr.201600557 · DOI · Paper page
- Tomás‐Barberán F. A., 2016, Urolithins, the rescue of 'old' metabolites to understand a 'new' concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and host health status, Mol. Nutr. Food Res.
- 10.1039/C5FO01100K · DOI
- 10.1016/j.chroma.2015.08.044 · DOI
- 10.1021/acs.jafc.5b02062 · DOI
- 10.3945/jn.109.112912 · DOI
- 10.1007/s11130-012-0325-x · DOI
- 10.1002/mnfr.201100673 · DOI · Paper page
- 10.1186/1743-7075-6-41 · DOI
- 10.1016/S0002-9149(03)00111-5 · DOI
- 10.1111/j.1574-6941.2009.00671.x · DOI · Paper page
- 10.1016/j.jff.2015.06.040 · DOI
- 10.1038/520609a · DOI · Paper page
- 10.1002/mnfr.201100531 · DOI
- 10.1002/mnfr.201100513 · DOI
- 10.1016/j.freeradbiomed.2013.05.046 · DOI · Paper page
- 10.1097/MCO.0000000000000314 · DOI · Paper page
- 10.1002/mnfr.201500940 · DOI
- 10.2174/13816128113199990407 · DOI · Paper page
- 10.1002/mnfr.201400866 · DOI
- 10.1002/mnfr.201400390 · DOI
- 10.1002/mnfr.201500091 · DOI
- 10.3945/ajcn.115.125690 · DOI
- EFSA. Scientific Opinion on the substantiation of health claims related to pomegranate/pomegranate juice and maintenance of normal blood cholesterol concentrations (ID 1162 1320 2107 2167) maintenance of normal erectile function (ID 1163) protection of lipids from oxidative damage (ID 1201 1319 2123) “antioxidant and anti‐aging properties” (ID 1901) increase in appetite after unintentional weight loss leading to an increase in energy intake (ID 2122) and maintenance of normal blood glucose concentrations (ID 4471) pursuant to Article 13(1) of Regulation (EC) No 1924/2006.EFSA J. 2010 8 1750 [22 pp.]. · doi:10.2903/j.efsa.2010.1750
- EFSA. Scientific opinion on the substantiation of a health claim related to a combination of pomegranate pomace extract and greater galangal rhizome powder and an increase in the number of motile spermatozoa in semen pursuant to Article 13(5) of Regulation (EC) No 1924/2006.EFSA J. 2015 13 4097 [16 pp.]. · DOI
- 10.1016/S0140-6736(11)60105-0 · DOI · Paper page
- Frankenfeld C. L., 2016, Cardiometabolic risk and gut microbial phytoestrogen metabolite phenotypes, Mol. Nutr. Food Res
- Reverri E. J., 2016, Metabolomics reveals differences between three daidzein metabolizing phenotypes in adults with cardiometabolic risk factors, Mol. Nutr. Food Res.
- 10.1021/jf049144d · DOI · Paper page
- 10.1016/j.jnutbio.2009.04.012 · DOI · Paper page
- 10.1016/j.bmcl.2011.07.086 · DOI
- 10.1002/mnfr.201500357 · DOI
- 10.1016/j.ijfoodmicro.2010.03.038 · DOI · Paper page
- 10.1039/C5FO00669D · DOI
- 10.1046/j.1365-2796.2002.01054.x · DOI
Cited by
The gut microbiota: a key factor in the therapeutic effects of (poly)phenols
Espín, J. C., González-Sarrías, A., & Tomás-Barberán, F. A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.033 · Cited by 603
Self-citationImpact of the natural compound urolithin a on health, disease, and aging
D’Amico, D., Andreux, P. A., Valdés, P., Singh, A., Rinsch, C., & Auwerx, J. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.04.009 · Cited by 419
Corrêa, T. A. F., Rogero, M. M., Hassimotto, N. M. A., & Lajolo, F. M. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00188 · Cited by 316
Prebiotic effect of dietary polyphenols: A systematic review
Alves-Santos, A. M., Sugizaki, C. S. A., Lima, G. C., & Naves, M. M. V. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104169 · Cited by 308
Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota
García‐Villalba, R., Giménez‐Bastida, J. A., Cortés‐Martín, A., Ávila‐Gálvez, M. Á., Tomás‐Barberán, F. A., Selma, M. V., Espín, J. C., & González‐Sarrías, A. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101019 · Cited by 302
Self-citation
Metadata
- Authors
- González‐Sarrías, A., García‐Villalba, R., Romo‐Vaquero, M., Alasalvar, C., Örem, A., Zafrilla, P., Tomás‐Barberán, F. A., Selma, M. V., & Espín, J. C.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2017-05
- Volume
- 61
- Issue
- 5
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2553070638
- Cited by
- 230
- References
- 5
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Ministerio de Economía y Competitividad (201370E068)
- Comisión Sectorial de Investigación Científica
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.